Over the past several years, Accelerate Diagnostics and our scientific collaborators have conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.Okay, I understand. Show me the publications.
Randomized Clinical Trial Evaluating Clinical Impact of RAPid IDentification and Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN)
Ritu Banerjee, Lauren Komarow, Abinash Virk, et al. (Antibacterial Resistance Leadership Group, Mayo Clinic, University of California Los Angeles)
Impact of Accelerate PhenoTM Rapid Blood Culture Detection System with Real Time Notification versus Standard Antibiotic Stewardship on Clinical Outcomes in Bacteremic Patients
Courtney Pearson, Katherine Lusardi, Kelsey McCain, et al. (University of Arkansas for Medical Sciences)
Real-World Impact of Accelerate Pheno Implementation with Antimicrobial Stewardship Intervention
Patrick Kinn, Kelly Percival, Michael Edmond, Bradley Ford, Dilek Ince (University of Iowa Hospitals and Clinics)
Attempting to Add Clarity to “Indeterminates” on a Deployed Rapid Diagnostic with Antimicrobial Stewardship Program (ASP) Intervention
Heather Cox, April Attai, Allison Stillwell, Kasi Vegesana, Frankie Brewster, Melinda Poulter, Amy Mathers (UVA Health)
Effectiveness of Antibiotic Neutralization with Broad-Spectrum Beta-Lactamase in Contrived Whole Blood Samples
ASM Microbe 2019
Yushkevich I, Giddins S, Fuchs M, Irwin A, Metzger S, Price C (Denver Health and Hospital Authority)
Evaluation of a Rapid Identification and Antimicrobial Susceptibility Test System from Positive Blood Cultures
Gibson C, Gee M, Imboden A, Jerke K (Madigan Army Medical Center)
Rapid Identification and Susceptibility Testing of Gram-Negative Rods from Positive Blood Cultures Using the Accelerate Pheno™ System: A Comparison Study in a Clinical Laboratory
ASM Microbe 2019
Whitlow C, Hailes J, Navas M (VA Northeast Ohio Healthcare System, Cleveland)
Performance of the Accelerate Diagnostics Blood Culture Detection System for Gram-Negative Bloodstream Infections in a Pediatric Hospital
Uprety P, Marino J, Cárdenas AM (Children’s Hospital of Philadelphia, University of Pennsylvania)
Time Comparison of Nine Phenotypic IVD Methods for Detection of Antibiotic Susceptibility in Clinical Blood Cultures: Reducing the Wait for Diagnosis
ASM Microbe 2019
Christina Chantell, Nathan Smith, Andy Chasteen (Accelerate Diagnostics)